| ISIN | CH1402520493 |
| Security | 140252049 |
| Symbol | Z0AQVZ |
| Currency | CHF |
| Currency hedging | No |
| Nominal amount | 1'000.00 |
| Coupon (Coupon p.a.) | KNIN + 5.15% |
| Coupon payment | guaranteed |
| Interest portion p.a. | KNIN |
| Premium portion p.a. | 5.150% |
| Coupon date | 23.02.2026 |
| Day count convention | 30/360 (German), modified following |
| Accrued coupon | n.a. |
| Issue price | 100.00% |
| Initial fixing date | 12.02.2025 |
| Payment day | 21.02.2025 |
| First trading day | 21.02.2025 |
| Last trading day | 14.02.2028 |
| Final fixing day | 14.02.2028 |
| Redemption date | 21.02.2028 |
| Redemption type | physical delivery or cash settlement |
| Early redemption | No |
| Residual term | 781 |
| Issue amount | 1'000'000.00 |
| Price status | flat Marchzins |
| Exchange | SIX Structured Products |
| Trade time | 09:15 - 17:15 (CET) |
| Round lot | CHF 1'000.00 |
| Performance of underlying since issue | -31.86% |
| SSPA derivative category | Yield enhancement |
| SSPA code | Reverse convertible (1220) |
| Issuer | Zuercher Kantonalbank Finance (Guernsey) Ltd |
| Keep-Well Agreement | with Zürcher Kantonalbank, Zürich |
| Issuer rating | |
| Lead manager | Zürcher Kantonalbank, Zürich |
| Payment, execution and calculation agent | Zürcher Kantonalbank, Zürich |
| Income tax | Yes |
| Withholding tax | No |
| Stamp duty payable in the secondary market | Yes |
| Stamp duty payable upon delivery of the securities | Yes |
| SIX Telekurs EU tax classification code | (out of scope) |
| Internal Rate of Return | n.a. |
| Cash value of fixed income investment upon issue | n.a. |
| Cash value of fixed income investment upon redemption | n.a. |
| USA, US persons, Guernsey, EEA, GB |
| Redemption date | 21.02.2028 |
| Redemption amount | |
| Redemption currency | n.a. |
| Underlying | n.a. |
| Physical delivery | - |
| ZKB Reverse Convertible auf Novo Nordisk A/S 140250665 / CH1402506658 |
| ZKB Barrier Reverse Convertible mit bedingtem Coupon, 24.06.2027 on worst of NVO UN/ROG SE/TEVA UN 144651781 / CH1446517810 |
| ZKB Barrier Reverse Convertible auf Novo Nordisk A/S 144652645 / CH1446526456 |
| ZKB Autocallable Barrier Reverse Convertible on worst of BASF SE/Novo Nordisk A/S/Vale SA 144652631 / CH1446526316 |
| ZKB Callable Barrier Reverse Convertible on worst of ASML Holding NV/Moët Hennessy Louis Vuitton SE/... 142530512 / CH1425305120 |